Filing Details

Accession Number:
0001209191-23-030167
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-17 16:21:18
Reporting Period:
2023-05-15
Accepted Time:
2023-05-17 16:21:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1688712 Carter Dawn Bir 5320 Legacy Dr.
Plano TX 75024
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-05-15 894 $85.09 31,302 No 4 S Direct
Class A Common Stock Disposition 2023-05-16 417 $80.96 30,885 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.